Rotavirus Vaccine & Health Care Utilization for Diarrhea in U.S Children N Engl J Med 2011;365:1108-17 Vanessa Craven Clinical Research Fellow.

Slides:



Advertisements
Similar presentations
Influenza and Shingles Vaccines August 2013
Advertisements

Rotavirus vaccine impact. Introduction. Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated.
Rotavirus vaccines Contentious issues and the way forward.
REACH Healthcare Foundation Prepared by Mid-America Regional Council 2013 Kansas City Regional Health Assessment.
RotaTeq ® Post Marketing Surveillance and Effectiveness Data Dr Swashraya Shah MSD India 24 Dec 2011.
Constructing a cost-effectiveness analysis for a vaccine to prevent rotavirus Roseann Dial RN N287E.
Burden of Rotavirus Disease & Impact of Rotavirus Vaccination Umesh D. Parashar, MBBS, MPH Lead, Viral Gastroenteritis Epidemiology Team Centers for Disease.
Foodborne viruses; Rotavirus. 2 Global Impact of Gastroenteritis
Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
Health Protection and Infectious Diseases in Merton Julia Groom Joint Consultant in Public Health –Merton 1 December 2010 Morden Community Forum.
Defining what the problem is Framing a research question FETP India.
Influenza Prevention We anticipate that there will be two types of influenza illness and two different types of influenza vaccine this year Seasonal influenza.
Chapter 5 Use of Health Services. Types of health service use for exacerbations of asthma.
Unintentional Fall Injuries and Deaths Among MA Older Adults, Ages 65 Years and Over Carrie Huisingh, MPH, Epidemiologist Holly Hackman, MD, MPH, Epidemiologist.
Quality improvement for asthma care: The asthma care return-on-investment calculator Ginger Smith Carls, M.A., Thomson Healthcare (Medstat) State Healthcare.
Quality improvement for asthma care: The asthma care return-on-investment calculator Ginger Smith Carls, M.A., Thomson Healthcare (Medstat) State Healthcare.
Monitoring Safety of Rotavirus Vaccines David Martin, MD, MPH CBER Office of Biostatistics and Epidemiology, FDA For presentation at the Vaccines and Related.
Triage Nurse Initiation of Corticosteroids in Paediatric Asthma is Associated With Improved Emergency Department Efficiency Zemak et al Pediatrics Volume.
Chapter 8 - Focus Chapter : Chronic obstructive pulmonary disease among people aged 55 years and over.
Program Development for Safety Net Institutions Catherine Deamant, MD Director, Palliative Care Services Cook County Health and Hospitals System Coleman.
Descriptive Epidemiology
Immunization in the Time of H1N1 Anne Schuchat, MD Rear Admiral, US Public Health Service Director, National Center for Immunization and Respiratory Diseases.
1 Taiwan’s National Health Insurance: What Worked and What Didn’t? Prepared for Conference on Public Health and Preventive Medicine 2010, The World Federation.
Rotavirus vaccine coverage among a 2010 birth cohort and risk factors for partial or no coverage, Washington State 2010 K. Stigi, C. DeBolt, K. Lofy Washington.
The EuroHOPE- project: Comparison of treatment and outcome for AMI and stroke patients in Europe On behalf of the EuroHOPE-team: Terje P. Hagen Department.
AcademyHealth 2007 Gender Differences in Healthcare Utilization at the End-of Life Andrea Kronman, MD MSc Boston University BIRCWH Faculty Scholar Women’s.
NEW DIRECTIONS AN INTENSIVE CASE MANAGEMENT PROGRAM Frequent Users of Healthcare Initiative Meeting September 2006.
Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.
Demographics and Associated Costs of Dying for Enrolled Veterans Preliminary Findings James Breckenridge, PhD James Hallenbeck, MD Co-Principal Investigators.
“Advancing Knowledge. Improving Life.” Impact of Ohio Medicaid Eric Seiber, PhD Ohio State University.
1 Otitis Media Results from the Kaiser Permanente Efficacy Trial Steven Black, MD, Henry Shinefield, MD and Bruce Fireman, MS Kaiser Permanente Vaccine.
How do low-income limited English proficient adults use ambulatory health services when they have health insurance and access to interpreters? Elinor A.
Do you agree with the authors’ conclusion? Strongly disagree - EStrongly agree - ANot sure - CSomewhat agree - BSomewhat disagree - D.
The changing vaccination landscape and the sources of vaccination data
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
N Engl J Med 2010; 362: January 28, 2010 Presenters ; Dr Ngwenya/Dr Nchimba.
Hospital Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger than 5 Years of Age Johannes Foster, Alfredo.
Uses of NH’s Claims Database: Comprehensive Health Care Information System (CHIS) Christine Shannon Office of Medicaid Business & Policy, NH DHHS July.
Federal Data Sources for Child Health Services Research Overview Pamela Owens, PhD Jane Sisk, PhD Jessica Banthin, PhD June 2006.
Pediatric ACOs The Characteristics of Pediatric Populations and Their Impact on ACOs.
Can we achieve rotavirus vaccine immunization worldwide by 202X? Global Vaccines 202X: Access, Equity, Ethics May 3, 2011.
Complete & Incomplete Kawasaki Disease: Two sides of the same coin
1 Improving Care for the Uninsured by Providing Links to Primary Care Susan H. Busch, Ph.D. 1 Sarah McCue Horwitz, Ph.D. 2 Kathleen M. B. Balestracci,
Framing a research question Chitra Grace A Scientist- C (PGDHE) NIE, Chennai RM Workshop for ICMR Scientists 01/11/2011.
The Impact of Cost Sharing on Middle-Income Children AcademyHealth Annual Research Meeting June 2008 Amy M Lischko.
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
Asthma in Utah County Presented by: Celeste Beck, MPH Utah Asthma Program Epidemiologist.
Update on Effectiveness and Safety of Rotavirus Vaccines Umesh D. Parashar Lead, Viral Gastroenteritis Team Centers for Disease Control Prevention Atlanta,
Trends in Tetanus Epidemiology in the United States, Pamela Srivastava MS Bacterial Vaccine-Preventable Disease Branch, National Immunization.
1 13-valent pneumococcal conjugate vaccine (PCV13) – new ACIP recommendations 44 th National Immunization Conference April 21, 2010 Pekka Nuorti, MD, DSc.
Immunisation  Learning Outcomes: Identify one stage in the NHS vaccination programme Recall key symptoms relating to one childhood disease Provide three.
A ssociation of Public Health Observatories Hospital Activity data Roy Maxwell SWPHO & Bristol University Dr Richard Wilson Sandwell PCT.
C. Jillian Tsai, Ph.D. Department of Preventive Medicine
Health economics of workplace HIV programmes A cost benefit analysis of Anglo Coal’s ART programme Gesine Meyer-Rath 1,2,3, Jan Pienaar 4, Brian Brink.
May 2011 Influenza in the UK ( ) HPA Report ‘Surveillance of influenza & other respiratory viruses in the UK’ (May 2011)
Impact of Rotavirus Vaccination in Latin America
Asthma in Australia Hospitalisations and emergency department visits
Research where it is most needed National Respiratory Strategy
Vaccine Efficacy, Effectiveness and Impact
Screening Mid-upper arm circumference (MUAC) MUAC<110mm
Amy Groom, MPH IHS Immunization Program Manager/CDC Field Assignee
NM S003: Rotavirus [27/11/2017] Marie C. Hill
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
WMQI Neonates 10 November 2011.
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Rotavirus Vaccines An Update
Presentation transcript:

Rotavirus Vaccine & Health Care Utilization for Diarrhea in U.S Children N Engl J Med 2011;365: Vanessa Craven Clinical Research Fellow

Image removed for copyright reasons

The Global Picture D&V in < 5yrs 111 million stay at home 25 million clinic visits 2 million hospitalisations deaths Joint Committee on Vaccination & Immunisation statement on rotavirus vaccine; 2008

And at Home… episodes hospitalised 3-4 deaths Joint Committee on Vaccination & Immunisation statement on rotavirus vaccine 2008

The Vaccines RotarixRotaTeq

The Vaccines Rotarix Live attenuated Oral 2 doses £35 per dose 6/52  6/12 No GI symptoms RotaTeq Live attenuated Oral 3 doses £25 per dose 6/52  6/12 ? Mild gut irritation Protection from 5 serotypes (88%) Intussusception & Kawasaki’s disease

The UK Stance NOT COST EFFECTIVE

What they did… < 5 yrs in U.S Comparison of: –Pre vaccine (01-06) vs Post vaccine (07-09) RV5 = RotaTeq Diarrhoea & specifically rotavirus Heath care use Costs

Highest age risk population Vaccine vs no vaccine Outcomes: Health care use (not just hospitals), direct & indirect effects & economics Not vaccine risk or full uptake Large number studied Data available Unvalidated economic tool What data was unavailable or incomplete?

Large numbers studied MarketScan database Studied those >6 months (not immunised) but analysed in age groups Medicaid NOT included 1/3 vaccine = immunised Vaccine rates not measured in universal programmes (13 states)

Accurate database? Partially vaccinated included Unvalidated vaccine coverage data & economic model RV1 excluded Non blinded Inpatient, ED, outpatient Excluded transition year Included indirect benefits Outcomes: Diarrhoea (all causes) & rotavirus Is rotavirus always tested for, especially if vaccine status is known

Only 2 years studied post vaccine Yearly fluctuations Unknown how many children had partial data

32% vaccinated (73% <1yr) by end of 2008 Hospitalisation RV ↓75% - all ages (07-08) ; ↓60% - proportional to coverage E.g↓26% in 2-4yrs (08-09) Largest effect in <1yr (↓76%) Diarrhoea↓33% (07-08) & ↓25% (08-09) Greatest ↓ during RV season & indirect ED visits ↓9% (07-08) & similar (08-09) except the West OP visits ↓3% (07-08) & similar (08-09) except the West But ED & OP ↑ in in 2-4yrs, Vaccinated vs Unvaccinated 89% ↓RV hospitalisation (small numbers in some regions) 44%/58% ↓Diarrhoea hospitalisation 37%/48% ↓ED 9%/12% ↓OP Similar indirect effect Geographical variation 08-09: $278 million saved

Complete dataset? Need more follow up Effect of partial immunisation Economic data Yes! Big effects Incomplete data Important adverse effects data excluded

Pre licensure study: ↓59% diarrhoea hospitalisation vaccinated vs unvaccinated Developed country Different vaccination system & healthcare system/approach Low socioeconomic group not included

Summary & Conclusions Obvious positive effects –Direct & indirect Adverse effects fully appreciated? Morbidity enough to justify investment?